Journal article · 2020 · Open access

Giving Voice to Clinical Study Participants: Development and Deployment of Sequential Patient Experience Surveys for Global Clinical Studies

Elizabeth Manning, Mitch Herndon, Wendy Frye, Tammy S. Ice, Nadia Thyssen, Daphnee S. Pushparajah, Stephen L. Yates

Therapeutic Innovation & Regulatory Science, 54(5), 1001–1009 · Published 21 January 2020 · DOI 10.1007/s43441-020-00115-5

Open PDFView at the publisherCite this paper

In brief

“Giving Voice to Clinical Study Participants: Development and Deployment of Sequential Patient Experience Surveys for Global Clinical Studies” is a 2020 journal article by Elizabeth Manning and 6 co-authors, published in Therapeutic Innovation & Regulatory Science. OpenAlex counts 4 citations as of 22 November 2026, which puts it in the top 7% of works published in 2020 by citations. It is open access under a CC BY licence: the full text is free to read at Therapeutic Innovation & Regulatory Science.

Citations
4
Most cited in
2024 (2)
References
17
Authors
7

Abstract

BACKGROUND: Biopharmaceutical companies are piloting patient experience surveys (PES) to help enhance patient satisfaction with clinical studies. However, most PES have been conducted at study close-out, which can hinder recall and responsiveness, and at a limited number of sites, which restricts their applicability to global studies. Our aim was to investigate the feasibility of developing sequential PES, which would be deployed globally, and to provide practical recommendations based on our real-world experience. METHODS: To develop sequential PES (introductory, interim, close-out), we customized a previously developed patient experience close-out survey. Extensive input was gained from multiple stakeholders (e.g., survey experts, patient advisors, psychometricians, clinical trialists, lawyers). To deploy the PES in global studies, we prepared PES-specific ethics committee submissions, training materials (e.g., slides, videos), and PES invitation aids (postcards, digital app reminders). RESULTS: Developing and deploying sequential PES in global clinical studies was feasible. The 3-part online PES (25 to 37 questions per survey) passed health literacy testing. To facilitate benchmarking, the PES included core questions (including a Net Promoter Score question). The PES gained ethics approval and was deployed globally in 2017-2018 in 12 phase 2 and 3 clinical studies in North America, Europe, and the Asia-Pacific. Based on the real-world insights gained and the challenges encountered, we have made recommendations for PES. CONCLUSIONS: Our practical recommendations on the development and deployment of sequential global PES may assist others to implement PES efficiently and effectively, allowing them to gain feedback from patients globally during clinical studies.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Manning, E., Herndon, M., Frye, W., Ice, T. S., Thyssen, N., Pushparajah, D. S., & Yates, S. L. (2020). Giving Voice to Clinical Study Participants: Development and Deployment of Sequential Patient Experience Surveys for Global Clinical Studies. Therapeutic Innovation & Regulatory Science, 54(5), 1001–1009. https://doi.org/10.1007/s43441-020-00115-5

MLA 9

Manning, Elizabeth, et al. “Giving Voice to Clinical Study Participants: Development and Deployment of Sequential Patient Experience Surveys for Global Clinical Studies.” Therapeutic Innovation & Regulatory Science, vol. 54, no. 5, 2020, pp. 1001–1009. https://doi.org/10.1007/s43441-020-00115-5.

Chicago

Manning, Elizabeth, Mitch Herndon, Wendy Frye, Tammy S. Ice, Nadia Thyssen, Daphnee S. Pushparajah, and Stephen L. Yates. 2020. “Giving Voice to Clinical Study Participants: Development and Deployment of Sequential Patient Experience Surveys for Global Clinical Studies.” Therapeutic Innovation & Regulatory Science 54 (5): 1001–1009. https://doi.org/10.1007/s43441-020-00115-5.

Harvard

Manning, E. et al. (2020) ‘Giving Voice to Clinical Study Participants: Development and Deployment of Sequential Patient Experience Surveys for Global Clinical Studies’, Therapeutic Innovation & Regulatory Science, 54(5), pp. 1001–1009. doi:10.1007/s43441-020-00115-5.

IEEE

E. Manning et al., “Giving Voice to Clinical Study Participants: Development and Deployment of Sequential Patient Experience Surveys for Global Clinical Studies,” Therapeutic Innovation & Regulatory Science, vol. 54, no. 5, pp. 1001–1009, 2020, doi: 10.1007/s43441-020-00115-5.

BibTeX

@article{manning2020giving,
  title     = {{Giving Voice to Clinical Study Participants: Development and Deployment of Sequential Patient Experience Surveys for Global Clinical Studies}},
  author    = {Manning, Elizabeth and Herndon, Mitch and Frye, Wendy and Ice, Tammy S. and Thyssen, Nadia and Pushparajah, Daphnee S. and Yates, Stephen L.},
  journal   = {Therapeutic Innovation \& Regulatory Science},
  year      = {2020},
  volume    = {54},
  number    = {5},
  pages     = {1001--1009},
  doi       = {10.1007/s43441-020-00115-5},
  url       = {https://doi.org/10.1007/s43441-020-00115-5}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Health Professions › General Health Professions › Patient Satisfaction in Healthcare

  • patient experience survey
  • clinical trial participants
  • patient satisfaction
  • Net Promoter Score
  • health literacy
  • survey development
  • stakeholder feedback
  • biopharmaceutical industry

Work with this paper

Most-cited papers in Health Professions

All highly cited Health Professions papers

Questions about this paper

How do I cite this paper in APA style?

Manning, E., Herndon, M., Frye, W., Ice, T. S., Thyssen, N., Pushparajah, D. S., & Yates, S. L. (2020). Giving Voice to Clinical Study Participants: Development and Deployment of Sequential Patient Experience Surveys for Global Clinical Studies. Therapeutic Innovation & Regulatory Science, 54(5), 1001–1009. https://doi.org/10.1007/s43441-020-00115-5

How many times has this paper been cited?

4 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Therapeutic Innovation & Regulatory Science: sign in and open the PDF from this page.

Who wrote this paper?

Elizabeth Manning, Mitch Herndon, Wendy Frye, Tammy S. Ice, Nadia Thyssen, Daphnee S. Pushparajah, Stephen L. Yates.

What is the DOI of this paper?

10.1007/s43441-020-00115-5, permanently at https://doi.org/10.1007/s43441-020-00115-5. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.